Loading clinical trials...
Loading clinical trials...
Phase 2 Study of ADXS11-001 in Subjects With Persistent/Recurrent, Loco-Regional or Metastatic Squamous Cell Carcinoma of the Anorectal Canal
Conditions
Interventions
Axalimogene filolisbac
Locations
10
United States
Duarte, California, United States
New Haven, Connecticut, United States
Indiana University
Indianapolis, Indiana, United States
Detroit, Michigan, United States
St Louis, Missouri, United States
Buffalo, New York, United States
Start Date
June 2, 2016
Primary Completion Date
January 3, 2019
Completion Date
January 3, 2019
Last Updated
March 20, 2023
NCT06204094
NCT07446322
NCT02600949
NCT05919264
NCT07541924
NCT07536113
Lead Sponsor
Advaxis, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions